National Viral Hepatitis Roundtable (NVHR)

What National Viral Hepatitis Roundtable (NVHR) does

NVHR (National Viral Hepatitis Roundtable) is a US-based nonprofit advocacy coalition founded in 2003 that operates as an initiative of the Hepatitis Education Project, a 501(c)(3) headquartered in Seattle, Washington. The organization functions as the largest national network uniting patients with lived experience, healthcare providers, public health leaders, and community partners to advance viral hepatitis elimination in the United States through policy advocacy, coalition-building, and education. Its work centers on Medicaid treatment access, harm reduction integration, equitable care for disproportionately impacted populations (people who inject drugs, incarcerated individuals, Baby Boomers, AAPI and African American communities), and implementation of federal testing and vaccination guidelines.

NVHR's programmatic portfolio includes the Hepatitis C: State of Medicaid Access project (with Harvard's Center for Health Law and Policy Innovation), the Voices4Hep patient and provider advocacy network, the HepNET cooperative agreement with CDC (alongside NASTAD and NACCHO), the Policy Innovation Exchange resource platform, monthly Network Calls, quarterly Hepatitis Roundtables co-hosted with the Hepatitis B Foundation and CDC's Division of Viral Hepatitis, and a library of webinars, fact sheets, and toolkits. The organization has been a recognized stakeholder in major federal milestones, including the 2006 'Eliminating Hepatitis: A Call to Action' presented to Congress, the 2010 Institute of Medicine report that spurred HHS's first viral hepatitis action plan, CMS coverage of Baby Boomer HCV screening (2015-2016), the 2023 White House National Hepatitis C Elimination Program proposal, and the FDA's 2024 approval of the first HCV RNA point-of-care test.

The business model is nonprofit grant-funded: NVHR charges no fees for its advocacy, educational, or coalition resources. Funding flows from foundations, government sources (including CDC cooperative agreements), individual donors, insurance companies, and pharmaceutical companies via the Hepatitis Education Project. Core staffing is lean — two program directors (Policy, Programs) plus an 8-member Advisory Committee of clinicians, researchers, and patient advocates, and 3 Perpetual Advisors. NVHR has no proprietary technology stack, no commercial software products, and operates across all 50 US states through state hepatitis coalitions and the Voices4Hep grassroots network.

Name

National Viral Hepatitis Roundtable (NVHR)

Legal name

National Viral Hepatitis Roundtable

Website

https://nvhr.org

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

1–10 employees

Short description

NVHR is a US-based nonprofit coalition that unites patients, providers, public health leaders, and community partners to advance viral hepatitis elimination through policy advocacy, Medicaid access work, and coalition-building, operating as an initiative of the Hepatitis Education Project.

Ownership category

akta.pro rank

Product category

Public Health Advocacy

NAICS

Voluntary Health Organizations (813212), Social Assistance (624), Health Care and Social Assistance (62)

SIC

Services-Social Services (8300), Services-Misc Health & Allied Services, Nec (8090), Services-Health Services (8000)

akta.pro primary industry

Disease-Specific Global Programs (HIV/TB/Malaria/NTDs) (HLAJAKAF)

akta.pro secondary industries

Disease-Specific Global Initiatives (HIV/TB/Malaria/NTDs) (HLAJAOAE), Non-Communicable Disease Prevention & Chronic Disease Programs (BPAIAJAI)

Keywords

• Viral hepatitis advocacy
• Public health coalition
• Hepatitis elimination programs
• Patient advocacy network
• Harm reduction policy

Headquarters

HQ city

Seattle

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Foundation and Government Funding: NVHR, as an initiative of the Hepatitis Education Project, receives funding from foundations and government sources to support advocacy, education, and policy work.
2. Individual Donors: The organization accepts donations from individual supporters to advance its mission of viral hepatitis elimination.
3. Pharmaceutical and Corporate Contributions: Hepatitis Education Project receives funding from pharmaceutical companies and insurance companies, which supports NVHR activities.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels9 records

Core offering

NVHR is a nonprofit advocacy coalition that unites patients, healthcare providers, public health leaders, and community partners to advance viral hepatitis B and C elimination in the United States. It delivers policy advocacy at federal and state levels, educational resources and webinars, coalition-building through the Voices4Hep network, Medicaid treatment-access research, and harm reduction integration initiatives. All programs are provided free of charge to stakeholders.

Product overview

NVHR is a nonprofit coalition organization (not a commercial product company) that operates as an initiative of the Hepatitis Education Project. The organization functions as a network of patients, providers, public health leaders, and community partners working to eliminate viral hepatitis in the United States. Rather than a unified software product, NVHR's portfolio consists of advocacy programs (Hepatitis C: State of Medicaid Access, Voices4Hep advocacy network), resource platforms (Policy Innovation Exchange), research networks (HepNET), and educational content (webinars, fact sheets, toolkits). These offerings are focused on advocacy, education, policy change, and community mobilization rather than commercial software products.

Differentiator

Problem solved

Functional benefit

Brands

• Voices4Hep: A network of patient, provider, and community advocates taking action in their communities to eliminate viral hepatitis.

Products and services

• Voices4Hep Advocacy Network National network connecting patient, provider, and community advocates who take action in their communities to eliminate viral hepatitis; members join, participate in monthly network calls, and engage in advocacy activities.
• Hepatitis C: State of Medicaid Access In-depth evaluation program that assesses direct-acting antiviral (DAA) access for hepatitis C treatment across state Medicaid programs, tracking treatment restrictions such as liver damage severity, sobriety requirements, and prescriber limitations.
• Hepatitis Network for Education and Testing (HepNET) Cooperative agreement with CDC, led in partnership with NASTAD and NACCHO, focused on identifying and addressing unmet needs of people who inject drugs to improve access to viral hepatitis care, education, prevention, testing, linkage to care, and treatment.
• Policy Innovation Exchange (PIX) National resource for state and local decision-makers, public health departments, and stakeholders to improve public health outcomes for HIV, viral hepatitis, STDs, and TB prevention.

Quantifiable outcome

• Inaugural meeting with 100+ organizations in 2003
• +6 more outcomes

Named customers4 records

Segments9 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

20 partnerships are on record, tiered core and secondary.

• Hepatitis Education ProjectcoreStrategic or Co-development Partner · 1 January 2019NVHR is an initiative of the Hepatitis Education Project (HEP), a nonprofit organization. In 2019, after 15 years as a fiscally-sponsored project, NVHR came under the umbrella of HEP. HEP provides organizational infrastructure and receives funding from foundations, governments, individual donors, insurance companies, and pharmaceutical companies to support NVHR's work.
• National Hepatitis Corrections Network (NHCN)coreStrategic or Co-development PartnerNVHR works alongside NHCN to support a comprehensive and integrated response to viral hepatitis. NHCN is a network focused on hepatitis C in correctional settings, and NVHR collaborates on policy and advocacy related to hepatitis care in prisons and jails.
• NASTADcoreStrategic or Co-development PartnerNASTAD (National Alliance of State & Territorial AIDS Directors) partners with NVHR on HepNET (Hepatitis Network for Education and Testing), a cooperative agreement with CDC. NASTAD leads the initiative in partnership with NVHR and NACCHO to improve viral hepatitis access for people who inject drugs.
• National Association of County and City Health Officials (NACCHO)coreStrategic or Co-development PartnerNACCHO partners with NVHR and NASTAD on the HepNET cooperative agreement with CDC to support public health partners, community-based organizations, tribal health organizations, and healthcare providers in viral hepatitis education and testing.
• Center for Health Law and Policy Innovation (CHLPI) at Harvard Law SchoolcoreStrategic or Co-development PartnerNVHR partners with CHLPI on the Hepatitis C: State of Medicaid Access project, which evaluates HCV treatment restrictions across state Medicaid programs. Together they released the foundational 2017 report and continue to track and advocate for removal of barriers including liver damage, sobriety, and prescriber limitations.
• National Academies of Sciences, Engineering, and MedicinecoreStrategic or Co-development PartnerNVHR was a sponsor of Phase 2 of the National Academies' Committee on a National Strategy for the Elimination of Hepatitis B & C, which released its report in March 2017 outlining specific actions to eliminate hepatitis B and C in the United States.
• Treatment Action GroupsecondaryStrategic or Co-development PartnerNVHR coordinates with Treatment Action Group on the Viral Hepatitis Diagnostics Working Group, advocating for accessible, affordable, effective, and rapid viral hepatitis diagnostics.
• O'Neill Institute for National and Global Health Law at Georgetown LawsecondaryStrategic or Co-development PartnerThe O'Neill Institute ran the Hep ElimiNATION project (January 2022 - August 2023) with consultation from NVHR and CHLPI, providing assessments of policies and programmatic strategies for viral hepatitis elimination across U.S. jurisdictions.
• Hepatitis B FoundationsecondaryStrategic or Co-development PartnerNVHR co-hosts Quarterly Hepatitis Roundtables with the Hepatitis B Foundation and CDC's Division of Viral Hepatitis. They also partner on adult hepatitis B vaccination advocacy through the Adult Vaccine Access Coalition.
• Coalition for Syringe AccesssecondaryStrategic or Co-development PartnerNVHR is a steering committee member of the Coalition for Syringe Access, a national organization working to provide syringe service programs and harm reduction. NVHR ensures viral hepatitis is included in drug user health discussions.
• Hep B UnitedsecondaryStrategic or Co-development PartnerNVHR is a member of Hep B United, a coalition working to address hepatitis B in Asian American and Pacific Islander communities. NVHR participates in coalition activities and policy advocacy.
• Adult Vaccine Access Coalition (AVAC)secondaryStrategic or Co-development PartnerNVHR participates in AVAC, which focuses on raising awareness and improving access to adult vaccines, including hepatitis B vaccination for adults.
• Urban Survivors UnionsecondaryStrategic or Co-development PartnerNVHR partnered with Urban Survivors Union on the 'More than Tested, Empowered' project addressing barriers to hepatitis C care faced by individuals who use drugs.
• People's Harm Reduction AlliancesecondaryStrategic or Co-development PartnerNVHR collaborated with People's Harm Reduction Alliance on the 'More than Tested, Empowered' project to identify and overcome barriers to hepatitis C care for people who use drugs.
• Atlanta Harm Reduction CoalitionsecondaryStrategic or Co-development PartnerNVHR partnered with Atlanta Harm Reduction Coalition on the 'More than Tested, Empowered' project addressing hepatitis C stigma and care barriers.
• Empire Liver FoundationsecondaryStrategic or Co-development PartnerNVHR partnered with Empire Liver Foundation on a webinar about prescribing buprenorphine in hepatitis care settings for patients with opioid use disorder.
• HepCuresecondaryStrategic or Co-development PartnerNVHR co-hosted webinars with HepCure on injection drug use health disparities among Puerto Ricans and implications for HCV care and elimination.
• Hep B UnitedsecondaryStrategic or Co-development PartnerNVHR co-hosted a congressional briefing on adult hepatitis B vaccination awareness with Hep B United, AAPCHO, AVAC, National Consumers League, and The AIDS Institute.
• Association of Asian Pacific Community Health Organizations (AAPCHO)secondaryStrategic or Co-development PartnerNVHR partnered with AAPCHO on hepatitis B advocacy and the 2015-2016 CMS coverage campaign for HCV screening in Baby Boomers and high-risk adults.
• Hepatitis Appropriations Partnership (HAP)secondaryStrategic or Co-development PartnerNVHR co-sponsored a Hill briefing on harm reduction strategies with HAP, Hep B United, NASTAD, The AIDS Institute, Hepatitis B Foundation, and AAPCHO.

Scale indicators7 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• National Association of County and City Health Officials (NACCHO): Large national association representing local health departments. NACCHO is a HepNET partner with NVHR, operating a broader portfolio of public health priorities but sharing the local-government coalition model.

Direct peers

• Hepatitis B Foundation: Direct disease-specific peer focused on hepatitis B advocacy, education, and research. NVHR co-hosts Quarterly Hepatitis Roundtables with Hepatitis B Foundation and CDC's Division of Viral Hepatitis, making it one of NVHR's closest operational peers.
• American Liver Foundation: National voluntary health organization for liver disease including viral hepatitis. NVHR co-hosted the 'Tune in to Hep C' benefit with American Liver Foundation in 2011, indicating long-standing peer collaboration in hepatitis-focused patient advocacy and fundraising.
• NASTAD (National Alliance of State & Territorial AIDS Directors): Public health association that co-leads the HepNET cooperative agreement with NVHR and CDC. NASTAD operates adjacent disease-focused advocacy for HIV with overlapping state health department relationships, sharing NVHR's policy and coalition model.
• Harm Reduction Coalition: National harm reduction advocacy organization. NVHR's Director of Policy previously chaired the Harm Reduction Coalition, and NVHR works to integrate viral hepatitis into drug user health — sharing overlapping populations and policy priorities.
• Treatment Action Group (TAG): Disease-specific advocacy organization focused on HIV, TB, and hepatitis C treatment access. NVHR coordinates with TAG on the Viral Hepatitis Diagnostics Working Group, sharing treatment-access advocacy methodology and federal policy focus.
• Hep B United: Coalition focused on hepatitis B in Asian American and Pacific Islander communities. Hep B United partners with NVHR on congressional briefings and adult hepatitis B vaccination advocacy, sharing the disease-specific, population-focused advocacy model.

Emerging players

• O'Neill Institute for National and Global Health Law: Georgetown-based health law institute that ran the Hep ElimiNATION project with NVHR consultation. Operates in adjacent policy and legal analysis space for hepatitis elimination strategy.
• Center for Health Law and Policy Innovation (CHLPI) at Harvard Law School: Academic legal and policy advocacy group. CHLPI co-leads the Hepatitis C: State of Medicaid Access project with NVHR, applying legal analysis to state treatment access — a complementary capability that strengthens NVHR's policy work.

Regional players

• National Viral Hepatitis Roundtable state coalitions (e.g., Virginia Hepatitis Coalition, Maryland Hepatitis Coalition, Hep Free Hawaii): State-level coalitions that NVHR supports and collaborates with. These are the operational extension of NVHR's national model at the state level, focusing on jurisdictional policy and local advocacy.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/national-viral-hepatitis-roundtable-nvhr-

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about National Viral Hepatitis Roundtable (NVHR)